KADIMA, Israel–(BUSINESS WIRE)–#ai–Vision Elements, a leading service provider offering customized research and algorithm development services…
The funding, led by new investor Tiger Global, will fuel Timescale’s thriving business, with 20x…
PITTSBURGH–(BUSINESS WIRE)–The Federal Home Loan Bank of Pittsburgh (FHLBank) announced today unaudited financial results for…
Acquisition signals a significant investment into deepening VistaVu’s industry experience and SAP Business One offerings…
Partnership Between the Companies Will Address Biometric Data Security Concerns and Enable Users to Secure…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that the company has entered into a…
FORT WORTH, TX , Feb. 22, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara” or…
CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified…
Patient data establishes key correlations for therapeutic exposure in tissue and alternative inflammatory pathways, supporting…
STI-9167 neutralizing antibody (nAb) maintains high neutralization potency against the recently emerging Omicron sublineage BA.2…
JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
QuantuMDx announces approval of its Rapid Q-POCTMSARS-CoV-2 assay in the UK under CTDA legislation NEWCASTLE…
Industry veteran with over 20 years of drug development experience to oversee advancement of Acer’s…
Data Published in Cancer Research, a journal of the American Association for Cancer Research Publication…
— Conference call and webcast to be held at 10:00 a.m. ET — BOSTON, Feb….
SEATTLE, Feb. 22, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
MARLBOROUGH, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
CAMBRIDGE, Mass. and NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…